Quarterly report pursuant to Section 13 or 15(d)

ASSET PURCHASE AGREEMENT WITH KATANA (Details Narrative)

v3.21.1
ASSET PURCHASE AGREEMENT WITH KATANA (Details Narrative) - Asset Purchase Agreement [Member] - Katana Pharmaceuticals, Inc [Member]
$ in Thousands
Dec. 22, 2020
USD ($)
Consideration paid $ 700
Cash $ 700